Evidence map›Paper›PMID 36884165›Full record

ArticleBiochemical genetics2023

Circ-FNDC3B Functions as an Oncogenic Factor in Esophageal Squamous Cell Carcinoma via Upregulating MYO5A by Absorbing miR-136-5p and miR-370-3p.

Yuanqiang Zhang, Wei Xiong, Chunping Yang, Ping Li, Huajie Tong

Abstract read
PubMed Publisher
In one paragraph

Article in Biochemical genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yuanqiang ZhangDepartment of Cardiothoracic Surgery, Zigong First People's Hospital, No.42nd, ShangYiHao Branch 1st, Zi Liu Jing District, Zigong City, 643000, Sichuan Province, China.
Wei XiongDepartment of Cardiothoracic Surgery, Zigong First People's Hospital, No.42nd, ShangYiHao Branch 1st, Zi Liu Jing District, Zigong City, 643000, Sichuan Province, China.
Chunping YangDepartment of Cardiothoracic Surgery, Zigong First People's Hospital, No.42nd, ShangYiHao Branch 1st, Zi Liu Jing District, Zigong City, 643000, Sichuan Province, China.
Ping LiDepartment of Cardiothoracic Surgery, Zigong First People's Hospital, No.42nd, ShangYiHao Branch 1st, Zi Liu Jing District, Zigong City, 643000, Sichuan Province, China.
Huajie TongDepartment of Cardiothoracic Surgery, Zigong First People's Hospital, No.42nd, ShangYiHao Branch 1st, Zi Liu Jing District, Zigong City, 643000, Sichuan Province, China. huajietong1965@126.com.ORCID http://orcid.org/0000-0002-8823-878X
Zigong First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circular RNAs (circRNAs) are a class of key regulators in cancers via regulating gene levels by acting as sponges of miRNAs. This study was devoted to explore the functional mechanism of circRNA fibronectin type III domain-containing protein 3B (circ-FNDC3B) in esophageal squamous cell carcinoma (ESCC). RNA levels were examined via reverse transcription-quantitative polymerase chain reaction assay. Cell viability detection was performed using Cell Counting Kit-8 assay. The proliferation ability was determined through colony formation assay and EDU assay. Flow cytometry was applied for analysis of apoptosis. Invasion ability was assessed via transwell assay. Target binding was analyzed by dual-luciferase reporter assay. The protein expression was measured using western blot. In vivo research was conducted via xenograft model in mice. Circ-FNDC3B exhibited significant upregulation in ESCC tissues and cells. Downregulation of circ-FNDC3B inhibited ESCC cell proliferation and invasion but accelerated cell apoptosis. Circ-FNDC3B interacted with miR-136-5p or miR-370-3p. The function of circ-FNDC3B was achieved by sponging miR-136-5p or miR-370-3p. Myosin VA (MYO5A) acted as a downstream target of miR-136-5p or miR-370-3p. MYO5A reversed miR-136-5p/miR-370-3p-induced tumor inhibition in ESCC cells. Circ-FNDC3B targeted miR-136-5p or miR-370-3p to affect MYO5A expression. Circ-FNDC3B knockdown reduced tumor growth in vivo by inhibiting miR-136-5p or miR-370-3p-mediated MYO5A expression. These findings demonstrated that circ-FNDC3B contributed to malignant progression of ESCC cells via miR-136-5p/MYO5A or miR-370-3p/MYO5A axis.

Indexed as

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaMicroRNAsMyosin Type VAnimalsApoptosisCell Line, TumorCell ProliferationCell SurvivalFibronectinsHumansMiceMyosin Heavy ChainsFibronectinsFNDC3B protein, humanMicroRNAsMIRN136 microRNA, humanMIRN370 microRNA, humanMYO5A protein, humanMyosin Heavy ChainsMyosin Type VCirc-FNDC3BEsophageal squamous cell carcinomamiR-136-5pmiR-370-3pMYO5A

Identifiers

PMID36884165
OpenAlexW4323530790

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.